Evogene Ltd. (EVGN)
0.5076
-0.03
(-5.63%)
USD |
NASDAQ |
Sep 08, 16:00
0.5002
-0.01
(-1.46%)
After-Hours: 20:00
Evogene Total Liabilities (Quarterly) : 4.542M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.542M |
| March 31, 2026 | 6.809M |
| December 31, 2025 | 4.998M |
| September 30, 2025 | 5.997M |
| June 30, 2025 | 17.27M |
| March 31, 2025 | 17.61M |
| December 31, 2024 | 20.70M |
| September 30, 2024 | 23.73M |
| June 30, 2024 | 16.78M |
| March 31, 2024 | 17.16M |
| December 31, 2023 | 17.99M |
| September 30, 2023 | 17.66M |
| June 30, 2023 | 17.89M |
| March 31, 2023 | 16.40M |
| December 31, 2022 | 16.67M |
| September 30, 2022 | 16.63M |
| June 30, 2022 | 6.908M |
| March 31, 2022 | 7.82M |
| December 31, 2021 | 8.577M |
| September 30, 2021 | 8.329M |
| June 30, 2021 | 6.928M |
| March 31, 2021 | 6.934M |
| December 31, 2020 | 11.34M |
| September 30, 2020 | 6.311M |
| June 30, 2020 | 6.608M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.223M |
| December 31, 2019 | 7.822M |
| September 30, 2019 | 7.039M |
| June 30, 2019 | 7.387M |
| March 31, 2019 | 7.742M |
| December 31, 2018 | 5.49M |
| September 30, 2018 | 5.13M |
| June 30, 2018 | 5.046M |
| March 31, 2018 | 4.772M |
| December 31, 2017 | 4.786M |
| September 30, 2017 | 4.797M |
| June 30, 2017 | 4.695M |
| March 31, 2017 | 5.828M |
| December 31, 2016 | 5.394M |
| September 30, 2016 | 5.756M |
| June 30, 2016 | 5.632M |
| March 31, 2016 | 4.751M |
| December 31, 2015 | 5.963M |
| September 30, 2015 | 5.221M |
| June 30, 2015 | 6.364M |
| March 31, 2015 | 6.819M |
| December 31, 2014 | 8.401M |
| September 30, 2014 | 6.78M |
| June 30, 2014 | 7.089M |
| March 31, 2014 | 7.318M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd. | 49.63M |
| Pluri, Inc. | 39.06M |
| Scinai Immunotherapeutics Ltd. | 5.443M |
| CollPlant Biotechnologies Ltd. | 4.297M |
| Regentis Biomaterials Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.44M |
| Shareholders Equity (Quarterly) | -3.29M |
| Debt to Equity Ratio | -0.6386 |
| Current Ratio | 3.566 |
| Net Debt Paydown Yield | 1.65% |